In parallel, CAF-derived TGF-β suppresses antigen-processing genes (e.g., TAP2, ERAP1, β2-microglobulin) via Smad3, reducing MHC-I surface expression and dampening tumor immunogenicity [151]. This evidence concerns the gene TGFB1 and neoplasm.